Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management, according to a team led by researchers from the ...

Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of ...

Autoimmune diseases, in which the immune system mistakenly attacks the body's own healthy cells and tissues, often include a ...

A German research team’s discoveries about autoimmune diseases are opening up new possibilities for patients with lupus and ...

Gigi Hadid lives a charmed life as an in-demand supermodel, but over the years she's been impressively open about her ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Monoclonal Antibody to Inhibit IL33 for Autoimmune Disorders is under clinical development by Eli Lilly and Co and currently in Phase I for Autoimmune Disorders.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

What is Known About the Estrogen Deficiency of Menopause & Specific Autoimmune Diseases It is known that many natural, pathological and therapeutic conditions can change serum estrogen levels ...

ONO-4915 is under clinical development by Ono Pharmaceutical and currently in Phase I for Autoimmune Disorders.

Elvis Presley died in 1977 at 42 years old. His autopsy report was sealed for 50 years and will be released in 2027. Various ...